St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
The SAMD9L Database is a curated repository of germline SAMD9L variants identified in patients through published literature. Our goal is to provide a comprehensive knowledge base for understanding SAMD9/9L syndromes.
If you are interested in contributing variants, please contact wlodarskilab@stjude.org
SAMD9L transcript version is NM_152703.2. Curated by Sushree Sahoo, PhD. Last updated: 07/29/2025.
Patient ID | SAMD9 mutation (cDNA) | SAMD9 mutation (Protein) | Type of mutation | Zygosity | Inheritance | CADD score | Mutation effect (HEK293 assay) | gnomAD (v4.1.0) population frequency | Year of reporting | PMID | Patient also reported in (PMID) | Original patient ID | Disease | Karyotype | Constitutional abnormalities | Hematopoietic phenotype | Infections | Somatic SAMD9L mutations | Other somatic mutations |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P001 | c.3587G>C | p.Cys1196Ser | Missense | Heterozygous | 21.9 | Absent | 2016 | 27259050 | 6947857 | II-4, Family2 | Ataxia pancytopenia | Yes | Yes | ||||||
P002 | c.3587G>C | p.Cys1196Ser | Missense | Heterozygous | 21.9 | Absent | 2016 | 27259050 | 6947857 | II-5, Family2 | Ataxia pancytopenia | Yes | Yes | ||||||
P003 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2016 | 27259050 | III-8, Family1 | Ataxia pancytopenia | Yes | Yes | ||||||
P004 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2016 | 27259050 | IV-2, Family1 | Ataxia pancytopenia | Yes | Yes | ||||||
P005 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2016 | 27259050 | IV-3, Family1 | Ataxia pancytopenia | UPD7q in patient derived LCL | Yes | Yes | |||||
P006 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2016 | 27259050 | III-6, Family1 | Ataxia pancytopenia | Yes | Yes | ||||||
P007 | c.3587G>C | p.Cys1196Ser | Missense | Heterozygous | 21.9 | Absent | 2016 | 27259050 | 6947857 | I-1, Family2 | Ataxia pancytopenia | Yes | No | ||||||
P008 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2016 | 27259050 | IV-1, Family1 | Ataxia pancytopenia | Yes | No | ||||||
P009 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2016 | 27259050 | III-5, Family1 | Ataxia pancytopenia | Yes | Yes | ||||||
P010 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2016 | 27259050 | II-4, Family1 | Ataxia pancytopenia | Yes | Yes | ||||||
P011 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2016 | 27259050 | III-3, Family1 | Ataxia pancytopenia | UPD7q in patient derived LCL | Yes | Yes | Yes | ||||
P012 | c.2672T>C | p.Ile891Thr | Missense | Heterozygous | 26.7 | Growth inhibited | Absent | 2017 | 28202457 | P8 (Family2:I-2) | MDS-LB | Yes | SAMD9L c.2302A>T (p.K768X; cis to germline SAMD9L) | ||||||
P013 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2017 | 28202457 | P3 (Family1:II-1) | MDS-LB | No | |||||||
P013 | NA | p.Thr233Asn | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2017 | 28202457 | P3 (Family1:II-1) | MDS-LB | No | |||||||
P014 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2017 | 28202457 | P4 (Family1:II-2) | MDS-LB | Yes | No | ||||||
P014 | NA | p.Thr233Asn | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2017 | 28202457 | P4 (Family1:II-2) | MDS-LB | Yes | No | ||||||
P015 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2017 | 28202457 | P1 (Family1:I-2) | MDS-LB | Yes | Yes | ||||||
P016 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2017 | 28202457 | P7 (Family1:III-2) | MDS-LB | UPD7q | Yes | ||||||
P017 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2017 | 28202457 | P5 (Family1:II-4) | MDS-LB | Yes | SAMD9L c.2957G>T; c.1204_1208del (p.R986L cis to germline SAMD9L; p.L410RfsX8) | ||||||
P018 | c.3842G>A | p.Arg1281Lys | Missense | Heterozygous | 14.69 | Growth inhibited | Absent | 2017 | 29146900 | P6 (SJ040280) | MDS-LB | Del(7)(q22q36) | Yes | ||||||
P019 | c.1877C>T | p.Ser626Leu | Missense | Heterozygous | 23.3 | Growth inhibited | Absent | 2017 | 29146900 | 31306780 | P8 (P7's relatives, SJ018225) | MDS-LB | Normal | Yes | MAP5, MYCBP2, RALGAPA1, RALGAPA1, SPIRE2, C17orf68, MAST3, ATP2B3, TAF1 | ||||
P020 | c.3538T>C | p.Trp1180Arg | Missense | Heterozygous | 12.68 | Growth inhibited | Absent | 2017 | 29146900 | 31306780 | P5 (SJ018198) | MDS-LB | Monosomy 7 | Yes | CACNA1S, TECR | ||||
P021 | c.1877C>T | p.Ser626Leu | Missense | Heterozygous | 23.3 | Growth inhibited | Absent | 2017 | 29146900 | 31306780 | P7 (SJ018222) | MDS-LB | Monosomy 7; 7q11.23-q36.3 del; UPD7q | Yes | C4orf40, PGAM2 | ||||
P022 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2017 | 28202457 | P2 (Family1:I-3) | MDS-LB | Duplication Chr1q; del(7q) | Yes | Yes | Yes | ||||
P023 | c.2672T>C | p.Ile891Thr | Missense | Heterozygous | 26.7 | Growth inhibited | Absent | 2017 | 28202457 | P9 (Family2:II-1) | MDS-LB | UPD7q | Yes | Yes | Yes | ||||
P024 | c.2672T>C | p.Ile891Thr | Missense | Heterozygous | 26.7 | Growth inhibited | Absent | 2017 | 28202457 | P10 (Family2:II-4) | MDS-LB | Monosomy 7; UPD7q | Yes | Yes | Yes | ||||
P025 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2017 | 28202457 | P6 (Family1:III-1) | MDS-LB | Yes | Yes | Yes | |||||
P026 | c.4477A>G | p.Ile1493Val | Missense | Heterozygous | 14.5 | Absent | 2018 | 29146883 | P8 (UB049) | Aplastic anemia | Monosomy 7 | Yes | |||||||
P027 | c.4561C>G | p.Leu1521Val | Missense | Heterozygous | 12.1 | 0.0032% | 2018 | 29146883 | P1 (UB195) | Aplastic anemia | Monosomy 7 | Yes | |||||||
P028 | c.2852_2853insACAC | p.Thr951fs | Frameshift | Absent | 2018 | 29146883 | P11 (UB112) | Aplastic anemia | Yes | ||||||||||
P029 | c.2519T>A | p.Met840Lys | Missense | Heterozygous | 22.8 | Absent | 2018 | 29146883 | P4 (UB194) | Aplastic anemia | Monosomy 7; del(6q) | Yes | |||||||
P030 | c.4648T>C | p.Ser1550Pro | Missense | 9.916 | Absent | 2018 | 29146883 | P5 (UB081) | Aplastic anemia | Yes | Yes | ||||||||
P031 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2018 | 29146883 | P2 (UB609) | Aplastic anemia | Yes | Yes | SAMD9L c.3337G>A (p.A1113T) | |||||
P032 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2018 | 29146883 | P3 (UB612, son of UB609) | Aplastic anemia | Transient monosomy 7 | Yes | Yes | |||||
P033 | c.3100G>T | p.Asp1034Tyr | Missense | 25 | Absent | 2018 | 29146883 | P9 (UB085) | MDS-LB | Yes | Yes | ||||||||
P034 | c.3427A>G, RTEL1 mutation carrier | p.Ser1143Gly | Missense | Heterozygous | 1.557 | Growth inhibited | 0.0012% | 2018 | 29146883 | P10 (UB260) | MDS-LB | Isochromosome 7q | Yes | ||||||
P035 | c.3442G>C, TERC mutation carrier | p.Asp1148His | Missense | Heterozygous | 21.4 | Absent | 2018 | 29146883 | P7 (Father of P6) | Transient thrombocytopenia | Yes | ||||||||
P036 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | Paternally inherited | 16.25 | Growth inhibited | Absent | 2018 | 29217778 | 34621053 | P5 (Family3, proband) | Familial MDS | UPD7q; Monosomy 7 | Yes | Yes | NRAS, RUNX1 | ||
P037 | c.2957G>A | p.Arg986His | Missense | Heterozygous | 24.6 | Growth inhibited | 0.0020% | 2018 | 29217778 | 31306780 | P3 (Family2, proband) | Familial MDS | Monosomy 7 | Yes | |||||
P038 | c.4534G>A | p.Val1512Met | Missense | Heterozygous | 25.2 | Growth inhibited | Absent | 2018 | 29217778 | 34621053 | P2 (Family1, sibling of P1) | Familial MDS | UPD7q; Transient monosomy 7 | Yes | |||||
P039 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2018 | 29217778 | 34621053 | P7 (Family4, proband) | Familial MDS | UPD7q; Transient monosomy 7 | Yes | SAMD9L c.3951_3955delTAAAG (p.S1317RfsX21; cis to germline SAMD9L) | PTPN11 | |||
P040 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2018 | 29217778 | P6 (Family3, father of P5) | Familial MDS | Del(7q) | Yes | ||||||
P041 | c.2640C>A | p.His880Gln | Missense | Heterozygous | 22.5 | Growth inhibited | Absent | 2018 | 30046003 | 1B (Sibling of 1A) | AML | Monosomy 7 | Yes | SETBP1, CBL, RUNX1, SETBP1, KRAS, BRAF | |||||
P042 | c.2640C>A | p.His880Gln | Missense | Heterozygous | Paternally inherited | 22.5 | Growth inhibited | Absent | 2018 | 30046003 | 1A (Proband) | AML | Monosomy 7 | Yes | No | RUNX1, SETBP1, CBL | |||
P043 | c.3842G>A | p.Arg1281Lys | Missense | Heterozygous | 14.69 | Growth inhibited | Absent | 2018 | 30046003 | 5C (Sibling of 5A) | MDS-LB | Yes | |||||||
P044 | c.3842G>A | p.Arg1281Lys | Missense | Heterozygous | 14.69 | Growth inhibited | Absent | 2018 | 30046003 | 5F (Sibling of 5A) | MDS-LB | Yes | SAMD9L c.3547C>T (p.Q1183*); c.3364A>T (p.T1122S); c.3365_3370del (p.1122_1124del); c.4189T>C (p.S1379P) | ||||||
P045 | c.3842G>A | p.Arg1281Lys | Missense | Heterozygous | 14.69 | Growth inhibited | Absent | 2018 | 30046003 | 5D (Sibling of 5A) | MDS-LB | UPD7q | Yes | SAMD9L c.2957G>T (p.R986L); c.3456_3458del (p.1152_1153del) | |||||
P046 | c.3842G>A | p.Arg1281Lys | Missense | Heterozygous | 14.69 | Growth inhibited | Absent | 2018 | 30046003 | 5B (Sibling of 5A) | MDS-LB | Yes | Yes | SAMD9L c.1082delT (p.V361fs) | |||||
P047 | c.3842G>A | p.Arg1281Lys | Missense | Heterozygous | 14.69 | Growth inhibited | Absent | 2018 | 30046003 | 5H (Sibling of 5A) | Transient monosomy 7 | Transient monosomy 7 | Yes | ||||||
P048 | c.3842G>A | p.Arg1281Lys | Missense | Heterozygous | 14.69 | Growth inhibited | Absent | 2018 | 30046003 | 5E (Sibling of 5A) | Transient monosomy 7 | Transient monosomy 7 | Yes | Yes | SAMD9L c.56T>A (p.V19E); c.1684G>A (p.E562K); 2326dupG (p.E776fs) | ||||
P049 | c.3842G>A | p.Arg1281Lys | Missense | Heterozygous | 14.69 | Growth inhibited | Absent | 2018 | 30046003 | 5G (Sibling of 5A) | Transient monosomy 7 | Transient monosomy 7; UPD7q | Yes | SAMD9L c.2527C>T (p.R843W); c.1765C>T (p.R589*) | |||||
P050 | c.4535T>C | p.Val1512Ala | Missense | Heterozygous | 21 | Growth inhibited | Absent | 2018 | 30046003 | 4B (Sibling of 4A) | Transient monosomy 7 | Transient monosomy 7 | SAMD9L c.1225delC (p.L409fs) | ||||||
P051 | c.1549T>C | p.Trp517Arg | Missense | Heterozygous | 25.1 | Growth increased | 0.0300% | 2018 | 30322869 | P2 (Father of P1) | Thrombocytopenia | Yes | |||||||
P052 | c.1549T>C | p.Trp517Arg | Missense | Heterozygous | Paternally inherited | 25.1 | Growth increased | 0.0300% | 2018 | 30322869 | P1 (Proband) | Transient severe pancytopenia | Normal | Yes | |||||
P053 | c.3442G>C, TERC mutation carrier | p.Asp1148His | Missense | Heterozygous | Paternally inherited | 21.4 | Absent | 2018 | 29146883 | P6 (UB022) | Aplastic anemia | Monosomy 7; del13q | Yes | Yes | |||||
P054 | c.2957G>A | p.Arg986His | Missense | Heterozygous | 24.6 | Growth inhibited | 0.0020% | 2018 | 29217778 | 31306780 | P4 (Family2, sibling of P3) | Familial MDS | Monosomy 7; del(7q) | Yes | Yes | ||||
P055 | c.4534G>A | p.Val1512Met | Missense | Heterozygous | 25.2 | Growth inhibited | Absent | 2018 | 29217778 | 34621053 | P1 (Family1, proband) | Familial MDS | Monosomy 7 | Yes | Yes | Yes | SAMD9L c.3562C>T (p.R1188*) | SETBP1, EZH2, KRAS, ETV6 | |
P056 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | Maternally inherited | 16.25 | Growth inhibited | Absent | 2018 | 30046003 | 3A (Proband) | MDS-LB | Monosomy 7 | Yes | Yes | SAMD9L c.3276C>G (p.F1092L) | |||
P057 | c.4535T>C | p.Val1512Ala | Missense | Heterozygous | 21 | Growth inhibited | Absent | 2018 | 30046003 | 4A (Proband) | Transient monosomy 7 | Transient monosomy 7; UPD (7q11.21-q36.3) | Yes | Yes | SAMD9L c.2338C>T (p.Q780*) | ||||
P058 | c.3842G>A | p.Arg1281Lys | Missense | Heterozygous | Maternally inherited | 14.69 | Growth inhibited | Absent | 2018 | 30046003 | 5A (Proband) | Transient monosomy 7 | Transient Monosomy 7; UPD7q | Yes | Yes | SAMD9L c.208C>T (p.R70C); c.838G>A (p.A280T); c.1076G>A (p.R359Q); c.3158C>T (p.T1053I); c.3274T>G (p.p.F1092V); c.3511G>A (p.D1171N) | |||
P059 | c.4418G>A | p.Ser1473Asn | Missense | Heterozygous | Paternally inherited | 20.9 | Growth inhibited | Absent | 2019 | 30923096 | IV-4 | Ataxia pancytopenia | Yes | Yes | |||||
P060 | c.4418G>A | p.Ser1473Asn | Missense | Heterozygous | Paternally inherited | 20.9 | Growth inhibited | Absent | 2019 | 30923096 | IV-1 | Ataxia pancytopenia / Pediatric ALL | Yes | SAMD9L c.1821_1822dupCA (p.S608TfsX6) | Common t(12,21) (ETV6-RUNX1) translocation | ||||
P061 | c.4418G>A | p.Ser1473Asn | Missense | Heterozygous | Paternally inherited | 20.9 | Growth inhibited | Absent | 2019 | 30923096 | IV-2 | Cytopenia | UPD7q | Yes | Yes | SAMD9L c.1382_1385delAAAG (p.E461VfsX43) | |||
P062 | c.4418G>A | p.Ser1473Asn | Missense | 20.9 | Growth inhibited | Absent | 2019 | 30923096 | III-1 (Father of IV-1 to 3) | Thrombocytopenia | Yes | Yes | |||||||
P063 | c.1076G>A | p.Arg359Gln | Missense | 17.52 | 0.0007% | 2019 | 31015479 | P1 | Ataxia pancytopenia | ||||||||||
P063 | c.3353A>G | p.Tyr1118Cys | Missense | 23.6 | Absent | 2019 | 31015479 | P1 | Ataxia pancytopenia | ||||||||||
P064 | c.2686T>G | p.Phe896Val | Missense | Heterozygous | De novo | 25 | Absent | 2019 | 31053103 | P1 | Leukoencephalopathy | Normal | Yes | Yes | |||||
P065 | c.4651 G>C | p.Val1551Leu | Missense | Heterozygous | De novo | 14.51 | Growth inhibited | Absent | 2019 | 31306780 | Blood-2018-99-120250 | P10 | MDS-LB | Monosomy 7 | Yes | Yes | Yes | ||
P066 | c.2658_2659delTT | p.Phe886LeufsX11 | Frameshift | Heterozygous | De novo | Growth inhibited | Absent | 2020 | 31874111 | P4 | SAAD | Yes | Yes | ||||||
P067 | c.2666delT | p.Phe889SerfsX2 | Frameshift | Heterozygous | De novo | Absent | 2020 | 31874111 | P6 | SAAD | Yes | Yes | |||||||
P068 | c.4525A>C | p.Ser1509Arg | Missense | Heterozygous | 23.5 | Growth inhibited | Absent | 2020 | 32770553 | P6 | MDS-LB | Monosomy 7 | No | Yes | SAMD9L c. 3023A>T (p.Lys1008Ile), c. 3540G>A (p.Trp1180*) | ||||
P069 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 16.25 | Growth inhibited | Absent | 2020 | 32808377 | P1 | Ataxia pancytopenia | Yes | No | ||||||
P070 | c.2658_2659delTT | p.Phe886LeufsX11 | Frameshift | Heterozygous | De novo | Growth inhibited | Absent | 2020 | 31874111 | P3 | SAAD | Yes | Yes | Yes | |||||
P071 | c.2626delA | p.Ile876LeufsX15 | Frameshift | Heterozygous | De novo | Absent | 2020 | 31874111 | P1 | SAAD | Yes | Yes | Yes | ||||||
P072 | c.2658_2659delTT | p.Phe886LeufsX11 | Frameshift | Heterozygous | De novo | Growth inhibited | Absent | 2020 | 31874111 | P5 | SAAD | Yes | Yes | Yes | |||||
P073 | c.2633delA | p.Lys878SerfsX12 | Frameshift | Heterozygous | De novo | Absent | 2020 | 31874111 | P2 | SAAD | Yes | Yes | Yes | ||||||
P074 | c.4519T>C | p.Trp1507Arg | Missense | Heterozygous | 25.4 | Growth inhibited | Absent | 2020 | 32770553 | P25 | Neutropenia | Monosomy 7 | No | Yes | Yes | No | |||
P075 | c.2483G>A | p.Arg828Gln | Missense | Heterozygous | 4.58 | No growth inhibition | 0.0010% | 2021 | 34621053 | A102 | MDS-LB | Normal | No | Yes | No | No | No | ||
P076 | c.2488G>T | p.Glu830X | Nonsense | Heterozygous | 35 | Growth inhibited | 0.0010% | 2021 | 34621053 | D339 | MDS-LB | Normal | Yes | Yes | No | No | No | ||
P077 | c.2957G>A | p.Arg986His | Missense | Heterozygous | 26.5 | Growth inhibited | 0.0020% | 2021 | 34621053 | D851 | MDS-LB | Normal | Yes | Yes | No | SAMD9L c.2085G>C (p.W695C; cis to germline SAMD9L) | No | ||
P078 | c.2957G>A | p.Arg986His | Missense | Heterozygous | 26.5 | Growth inhibited | 0.0020% | 2021 | 34621053 | B052 | MDS-LB | Monosomy 7 | No | Yes | No | No | No | ||
P079 | c.505G>C | p.Asp169His | Missense | Heterozygous | 24.2 | Growth inhibited | 0.0100% | 2021 | 34621053 | I363 | MDS-LB | Monosomy 7 | No | Yes | No | No | No | ||
P080 | c.1909G>A | p.Ala637Thr | Missense | Heterozygous | 20.8 | Growth inhibited | 0.0120% | 2021 | 34621053 | D570 | MDS-LB | Normal | No | Yes | No | No | No | ||
P081 | c.2069G>A | p.Gly690Asp | Missense | Heterozygous | 25.2 | Growth inhibited | 0.0380% | 2021 | 34621053 | D1095 | MDS-LB | Normal | No | Yes | No | No | No | ||
P082 | c.2069G>A | p.Gly690Asp | Missense | Heterozygous | 25.2 | Growth inhibited | 0.0380% | 2021 | 34621053 | D1160 | MDS-LB | Normal | No | Yes | No | No | No | ||
P083 | c.2069G>A | p.Gly690Asp | Missense | Heterozygous | 25.2 | Growth inhibited | 0.0380% | 2021 | 34621053 | D1267 | MDS-LB | Normal | No | Yes | No | No | No | ||
P084 | c.4046C>T | p.Pro1349Leu | Missense | Heterozygous | 1.807 | Growth inhibited | Absent | 2021 | 34621053 | D1300 | MDS-LB | Monosomy 7 | Yes | Yes | No | SAMD9L c.768dupT (p.K257X; cis to germline SAMD9L) | RUNX1 | ||
P085 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 21.7 | Growth inhibited | Absent | 2021 | 34621053 | CZ035 | MDS-LB | Monosomy 7 | No | Yes | No | SAMD9L c.3230G>A (p.R1077Q; cis to germline SAMD9L) | No | ||
P086 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 21.7 | Growth inhibited | Absent | 2021 | 34621053 | D743 | MDS-LB | Monosomy 7 | Yes | Yes | No | SAMD9L c.1765C>T (p.R589X; cis to germline SAMD9L) | No | ||
P087 | c.4418G>A | p.Ser1473Asn | Missense | Heterozygous | 26.7 | Growth inhibited | Absent | 2021 | 34621053 | CZ060 | MDS-LB | Monosomy 7 | Yes | Yes | No | No | No | ||
P088 | c.2675T>G | p.Met892Arg | Missense | Heterozygous | 24.6 | Growth inhibited | Absent | 2021 | 34621053 | D1297 | MDS-LB | Monosomy 7; UPD7q | No | Yes | No | No | No | ||
P089 | c.4420A>C | p.Thr1474Pro | Missense | Heterozygous | 23.1 | Growth inhibited | Absent | 2021 | 34621053 | GR012 | MDS-LB | Monosomy 7 | Yes | Yes | No | No | No | ||
P090 | c.2308A>G | p.Lys770Glu | Missense | Heterozygous | 16.49 | Growth inhibited | Absent | 2021 | 34621053 | D1215 | MDS-LB | Normal | Yes | Yes | No | No | No | ||
P091 | c.2956C>T | p.Arg986Cys | Missense | 16.25 | Growth inhibited | Absent | 2021 | 32054657 | P47 | Ataxia pancytopenia | 46,XY,t(3;21)(q26;q22) | Yes | Yes | CBL | |||||
P092 | c.215A>G | p.Tyr72Cys | Missense | Heterozygous | 0.005 | Growth inhibited | Absent | 2021 | 34621053 | D393 | MDS-LB | Normal | Yes | Yes | No | No | No | ||
P093 | c.2957G>A | p.Arg986His | Missense | 24.6 | Growth inhibited | 0.0020% | 2021 | 33368157 | #25 | MDS-LB | Monosomy 7 | Yes | SAMD9L c.2482C>T (p.Arg828*), c.3178G>T (p.Glu1060*) | ||||||
P094 | c.2807C>T | p.Thr936Ile | Missense | 15.45 | Absent | 2021 | 33368157 | #3 | MDS-LB | 7q-, Monosomy 7 | Yes | SAMD9L c.1765C>T (p.Arg589*) | |||||||
P095 | c.4736A>G | p.Tyr1579Cys | Missense | 24.5 | Absent | 2021 | 33368157 | #40 | MDS-LB | Yes | |||||||||
P096 | c.2308A>G | p.Lys770Glu | Missense | Heterozygous | 16.49 | Growth inhibited | Absent | 2021 | 34621053 | D1285 | MIRAGE | Monosomy 7; UPD7q | Yes | Yes | No | SAMD9L c.1765C>T (p.R589X; cis to germline SAMD9L) | CBL, KMT2C | ||
P097 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | De novo | 16.25 | Growth inhibited | Absent | 2021 | 33884299 | P1 | Ataxia pancytopenia with MDS | Interstitial deletion Chr 7q11.23 to q33 | Yes | Yes | ||||
P098 | c.1993A>C | p.Thr665Pro | Missense | Heterozygous | 9.034 | Growth inhibited | Absent | 2021 | 34621053 | CH026 | MIRAGE | Normal | No | Yes | No | No | |||
P099 | c.2915T>C | p.Ile972Thr | Missense | Heterozygous | 23.4 | Growth inhibited | Absent | 2021 | 34722875 | P1 | Ataxia with neuropathy | Normal | Yes | No | No | SAMD9L c.3229C>T, c.3456_3458del (p.R1077*, p.L1153del) | |||
P100 | c.2658_2659delTT | p.Phe886LeufsX11 | Frameshift | Heterozygous | De novo | Growth inhibited | Absent | 2021 | 33724365 | P1 | B-cell aplasia and autoinflammation | Yes | Yes | Yes | |||||
P101 | c.2633delA | p.Lys878SerfsX13 | Frameshift | Heterozygous | De novo | Growth inhibited | Absent | 2021 | 34417303 | P2 (Family2) | Leukocytoclastic panniculitis with B-cell lymphopenia | Yes | Yes | Yes | |||||
P102 | c.2654delA | p.Asn885TfsX6 | Frameshift | Heterozygous | De novo | Growth inhibited | Absent | 2021 | 34417303 | P1 (Family1) | Leukocytoclastic panniculitis with B-cell lymphopenia | Yes | Yes | Yes | |||||
P103 | c.2627T>C | p.Ile876Thr | Missense | Heterozygous | 24.9 | Growth inhibited | Absent | 2021 | 34621053 | D927 | MDS-EB | Monosomy 7 | Yes | Yes | Yes | SAMD9L c.1360G>A (p.G454R; cis to germline SAMD9L) | ASXL1, CBL, RUNX1, SETBP1 | ||
P104 | c.2483G>A | p.Arg828Gln | Missense | Heterozygous | 4.58 | No growth inhibition | 0.0010% | 2021 | 34621053 | D423 | MDS-LB | Normal | No | Yes | Yes | No | No | ||
P105 | c.2957G>A | p.Arg986His | Missense | Heterozygous | 26.5 | Growth inhibited | 0.0020% | 2021 | 34621053 | D1248 | MDS-LB | Monosomy 7; UPD7q | No | Yes | Yes | SAMD9L c.4571G>A (p.R1524H; cis to germline SAMD9L) | EZH2 | ||
P106 | c.2675T>G | p.Met892Arg | Missense | Heterozygous | 24.6 | Growth inhibited | Absent | 2021 | 34621053 | H005 | MDS-LB | Monosomy 7; UPD7q | Yes | Yes | Yes | No | SETBP1 | ||
P107 | c.3346A>C | p.Asn1116His | Missense | Heterozygous | 23.3 | Growth inhibited | Absent | 2021 | 34621053 | D1127 | MDS-LB | Monosomy 7 | Yes | Yes | Yes | No | No | ||
P108 | c.4537T>C | p.Trp1513Arg | Missense | Heterozygous | 24.7 | Growth inhibited | Absent | 2021 | 34621053 | D171 | MDS-LB | Monosomy 7 | No | Yes | Yes | No | No | ||
P109 | c.3843G>T | p.Arg1281Ser | Missense | Heterozygous | 22.3 | Growth inhibited | Absent | 2021 | 34621053 | D991 | MDS-LB | Monosomy 7 | No | Yes | Yes | SAMD9L c.2306dupA (p.N769KfsX5; cis to germline SAMD9L) | No | ||
P109 | c.1905G>T | p.Leu635Phe | Missense | Heterozygous | 24.6 | Growth inhibited | Absent | 2021 | 34621053 | D991 | MDS-LB | Monosomy 7 | Yes | SAMD9L c.2306dupA (p.N769KfsX5; cis to germline SAMD9L) | No | ||||
P110 | c.2800G>C | p.Asp934His | Missense | Heterozygous | 20.1 | Absent | 2022 | 34418069 | P1 (HT102) | Ataxia with cerebellar atrophy | No | Yes | |||||||
P111 | c.2626delA | p.Ile876LeufsX15 | Frameshift | Heterozygous | De novo | Absent | 2022 | 34848396 | P1 | SAAD | Normal | Yes | Yes | No | |||||
P112 | c.2062T>A | p.Tyr688Asn | Missense | 24.8 | Absent | 2022 | 36519557 | P1 | Ataxia pancytopenia | Monosomy 7 | Yes | No | No | ETV6 | |||||
P113 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 21.7 | Growth inhibited | Absent | 2022 | 36553623 | P1 (II-3) | Neuropathy | UPD7q | Yes | Yes | No | No | |||
P114 | c.2956C>T | p.Arg986Cys | Missense | Heterozygous | 21.7 | Growth inhibited | Absent | 2022 | 36553623 | P2 (III-1) | Neuropathy | Yes | No | No | SAMD9L c.3283A>G (p.K1095E) | ||||
P115 | c.1877C>T | p.Ser626Leu | Missense | Heterozygous | 23.3 | Growth inhibited | Absent | 2022 | 35310830 | P1 (III:7) | Spinocerebellar ataxia 49 | Yes | No | ||||||
P116 | c.1877C>T | p.Ser626Leu | Missense | Heterozygous | 23.3 | Growth inhibited | Absent | 2022 | 35310830 | P2 (IV:2) | Spinocerebellar ataxia 49 | Yes | No | ||||||
P117 | c.1877C>T | p.Ser626Leu | Missense | Heterozygous | 23.3 | Growth inhibited | Absent | 2022 | 35310830 | P3 (IV:8) | Spinocerebellar ataxia 49 | Yes | No | ||||||
P118 | c.1877C>T | p.Ser626Leu | Missense | Heterozygous | 23.3 | Growth inhibited | Absent | 2022 | 35310830 | P4 (IV:14) | Spinocerebellar ataxia 49 | Yes | No | ||||||
P119 | c.1877C>T | p.Ser626Leu | Missense | Heterozygous | 23.3 | Growth inhibited | Absent | 2022 | 35310830 | P5 (V:1) | Spinocerebellar ataxia 49 | No | Yes | ||||||
P120 | c.3800G>T, FLT3 carrier | p.Cys1267Phe | Missense | Heterozygous | 23.5 | 0.0010% | 2022 | 36012751 | P1 | Aplastic anemia | Yes | ||||||||
P121 | c.4303T>C | p.Trp1435Arg | Missense | Heterozygous | Maternally inherited | 29.3 | 0.0010% | 2022 | 36499545 | P2 (Family 2, proband) | Aplastic anemia | Yes | |||||||
P122 | c.4303T>C | p.Trp1435Arg | Missense | Heterozygous | 29.3 | 0.0010% | 2022 | 36499545 | P3 (Family 2, mother of P2) | Chronic thrombocytopenia | Yes | Yes | |||||||
P123 | c.2658-2659del | p.Phe886LeufsX11 | Frameshift | Heterozygous | De novo | Growth inhibited | Absent | 2022 | 34894360 | P1 | SAAD | Normal | Yes | Yes | Yes | ||||
P124 | c.2581C>T | p.Leu861Phe | Missense | Heterozygous | 25 | Absent | 2022 | 36054901 | P1 | Ataxia pancytopenia | No | No | Yes | Yes | |||||
P125 | c.4519T>C | p.Trp1507Arg | Missense | Heterozygous | De novo | 25.4 | Growth inhibited | Absent | 2023 | 36730951 | P2 | MDS-LB | Monosomy 7 | Yes | Yes | Yes | |||
P126 | NA | p.Lys1532Asn | Missense | Heterozygous | De novo | Absent | 2023 | 37357006 | P1 | MDS-EB | Monosomy 7 | Yes | Yes | Yes | SAMD9L (p.E685del) | RUNX1, WT1, EVI1, PRAME | |||
P127 | c.2666delT | p.Phe889SerfsX2 | Frameshift | Heterozygous | De novo | Absent | 2023 | 36969289 | P1 | SAAD | No | Yes | Yes | ||||||
P128 | c.3052G>A | p.Glu1018Lys | Missense | Heterozygous | Paternally inherited | 19.26 | 0.0001% | 2024 | 38597819 | P1 | Severe aplastic anemia | Yes | |||||||
P129 | c.2663C>T | p.Ser888Phe | Missense | Heterozygous | 25.3 | Absent | 2025 | 40725152 | P1 | MDS | SAMD9L C.3920T>C (P.F1370S) | ||||||||
Abbreviations:
ALL: acute lymphoblastic leukemia, AML: acute myeloid leukemia, CADD: combined annotation dependent depletion in silico pathogenic scoring, Del: deletion, LCL: lymphoblastoid cell lines, MDS: myelodysplastic syndrome, MDS-EB: MDS with excess blast, MDS-LB: MDS with low blast, SAAD: SAMD9L-mediated autoinflammatory disease, UPD: uniparental isodisomy,